< Terug naar vorige pagina

Octrooi

Colon cancer

The present invention relates generally to a method of predicting clinical outcome in a subject diagnosed with colorectal cancer comprising determining evidence of a miRNA profile or the expression of one or more predictive RNA transcripts in a biological sample, in particular a biological sample of cancer cells obtained from the subject. It further concerns using the profile a prognostic miRNA signature for relapse-free survival (RFS) in prognosis of a patient for colorectal cancer, in particular stage III colon cancer, and recurrence or response to therapy for colon cancer, in particular stage III colon cancer.
Octrooi-publicatienummer: WO2016115609
Jaar aanvraag: 2016
Jaar toekenning: 2017
Jaar van publicatie: 2016
Status: Aangevraagd
Technologiedomeinen: Biotechnologie
Gevalideerd voor IOF-sleutel: Ja
Toegewezen aan: Associatie KULeuven